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Abstract. This paper concerns classification of high-dimensional yet small sam-
ple size biomedical data and feature selection aimed at reducing dimensionality
of the microarray data. The research presents a comparison of pairwise com-
binations of six classification strategies, including decision trees, logistic model
trees, Bayes network, Na¨ıve Bayes, k-nearest neighbours and sequential minimal
optimization algorithm for training support vector machines, as well as seven
attribute selection methods: Correlation-based Feature Selection, chi-squared,
information gain, gain ratio, symmetrical uncertainty, ReliefF and SVM-RFE
(Support Vector Machine-Recursive Feature Elimination). In this paper, SVM-
RFE feature selection technique combined with SMO classifier has demonstrated
its potential ability to accurately and efficiently classify both binary and multi-
class high-dimensional sets of tumour specimens.
Keywords: feature selection, classification, high-dimensional tumour biomedi-
cal datasets.
1. Introduction
Feature selection and classification methods have become of particular interest in
the field of bioinformatics as the high-dimensional nature of biomedical data makes
the process of characterizing samples a challenging task. Nowadays, biomedical data
are usually high-dimensional, frequently containing thousands of features yet much
fewer samples. There is no denying that more information gives a better chance
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for knowledge discovery. Due to the curse of dimensionality, researchers face serious
issues connected with the fact that the number of genes (features) far exceeds the size
of the dataset examples. Thus, dimensionality reduction appears to be crucial for the
effective classification of tumour samples. This can be achieved by applying either
feature extraction or feature selection methods before construction of the classification
model. When compared to feature extraction, gene selection does not alter the original
representation of genes. Hence, it may not only enhance the performance of tumour
classification by removal of both redundant and irrelevant genes, but also determine
the informative gene subsets, capable of serving as tumour biomarkers and potential
drug targets. As already mentioned, details concerning tumour development are still
obscure. In order to potentially address this problem, feature selection seems to
be able to provide deep insight into the underlying molecular mechanism of tumour
development.
The aim of this paper is to create a comparison of pairwise combinations of fea-
ture selection methods and classification techniques applied to the problem of binary
and multi-class cancer classification. Even though both binary and multi-class sam-
ple classification have been studied extensively over the past few years [14, 15, 17],
no exact solution has been discovered. Nowadays, still there is no perfect combina-
tion of feature selection and classification methods as applied to high-dimensional yet
small sample size microarray data. This research does not only constitute an inde-
pendent contribution to the relevant literature, but also strive for finding a successful
way to perform efficient feature selection enhancing accurate classification of tumour
specimens.
The rest of the paper is organized as follows. In Section 2 we describe the method-
ology of our research. Section 3 is dedicated to the experiments conducted on sample
data and the results. Finally, in Section 4, the concluding remarks are discussed.
2. Feature selection and classification methods in terms of cancer diag-
nosis
High-throughput technologies used in the fields of genomics and proteomics provide
the opportunity to examine a large number of biological samples simultaneously. This
leads to high amounts of multivariate data corresponding to different biological as-
pects such as various variants of a disease, different stages of a disease, as well as
different survival rates and responses to treatment agents. Having a possibility to
look at the expression levels of thousands of genes and proteins is, of course, benefi-
cial, yet only to some extent. The problem occurs when there are only few samples
available, increasing the risk of overfitting the data, especially leading to unsatisfac-
tory classification in terms of new data points. What is more, using a classifier that is
too complex for the quantity of available data can only promote overfitting. In partic-
ular, high complexity can be induced by too many features present in the examined
data. Therefore, feature selection is exceptionally crucial in the case of biological
research where sample size is usually limited [2, 15].
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The proposed methodology of choosing best pairwise combinations of feature se-
lection and classification methods consists of four steps:
 data pre-processing, which results in the initial dataset;
 feature selection, which enables the choice of the set of attributes crucial for the
automated diagnosis;
 classification process based on the attributes derived from the previous step;
 verification by assessing appropriate comparison criteria.
Data pre-processing includes two main steps: firstly excluding housekeeping genes
and then normalization. In general, housekeeping genes take part in basic cell main-
tenance, and hence are supposed to maintain constant expression levels in all cells
and conditions [3]. This indicates that housekeeping genes may provide serious re-
dundancy and noise into the classification once these are chosen by attribute selection
methods. Therefore, these genes are to be removed from the datasets before applying
feature selection techniques. Identification of these genes facilitates exposure of the
underlying cellular infrastructure and increases understanding of functional charac-
teristics, evolutionary as well as various structural genomic and epigenetic features
[1, 3]. However Affymetrix (American manufacturer of DNA microarrays) housekeep-
ing genes IDs are marked in datasets by the prefix ‘AFFX-’ and therefore can be
identified automatically. Tissue specific (TS) genes are those genes which are only or
chiefly expressed in a certain tissue or an organ, and thus in charge of particular func-
tions and development. Tissue specific genes provide relevant information in terms
of classification so that these are to be maintained and subjected to experiments.
Besides, the values in the datasets are normalized (standardized) so that every gene
expression value is characterized by mean of zero and unit variance.
The main purpose of feature selection is to extract the smallest feature subset
using a defined generalization error, or finding the best feature subset with k features
which provides the minimum generalization error. There is a number of additional
benefits connected with feature selection. Firstly, it improves the generalization per-
formance concerning the model created using the entire set of features. Secondly,
it offers a substantially more robust generalization and a faster response with test
data. Moreover, feature selection enables researchers to gain a deeper insight into the
underlying processes that generated the data [9].
In this paper, seven feature selection methods are used: Correlation-based Fea-
ture Selection (CFS), Chi-squared, Information Gain, Gain Ratio, Symmetrical Un-
certainty, ReliefF and SVM-RFE. All of these feature selection methods except for
SVM-RFE (support vector machine method and recursive feature elimination intro-
duced by Guyon et al. [4]) belong to filter algorithms. They are well-suited for
high-dimensional datasets, in terms of accuracy, time as well as memory efficiency
[11], [13].
For the classification purpose we will consider six approaches: J48, logistic model
trees (LMT), Bayes network (BayesNet), Na¨ıve Bayes (NaiveBayes), k-nearest neigh-
bours (IBk) and sequential minimal optimization algorithm for training support vec-
tor machines (SMO). These classifiers are used in order to compare feature selection
methods discussed in this paper.
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Table 1. Datasets description.
Dataset No. Initial no. No. of features No. of
name of samples of features after pre-processing classes
ALL/AML 72 7129 7070 2
CNS 60 7129 7070 2
Colon 62 2000 1988 2
Lung 181 12600 12533 2
Lymphoma 96 4026 4026 11
GCM 192 16063 16004 14
In order to assess the performance of various pairwise combinations of feature
selection and classification methods, following comparison criteria have been used:
accuracy, sensitivity, specificity, FP rate, precision, root mean square error as well as
the number of features used while performing a given test.
3. Experimental analysis and results
There were six different either binary or multi-class cancer microarray gene expres-
sion datasets used in the research: Colon Cancer Dataset (binary), Lung Cancer
Dataset (binary), ALL/AML Dataset (binary), Lymphoma Dataset (multi-class),
GCM Dataset (multi-class) and CNS Dataset (binary). The summary of all the sets
of biomedical data is given in Table 1. Additionally, Table 1 includes the number of
genes before and after the pre-processing stage (i.e. removal of housekeeping genes).
The final results of pairwise combinations of feature selection techniques and clas-
sification methods are presented in Table 3. The best classification results without
conducting any feature selection method are shown in Table 2.
In the case of classifications conducted without the usage of any feature selection
method, SMO significantly outperformed other classifiers in terms of classification
accuracy. In the case of both binary leukaemia and multi-class lymphoma datasets,
SMO achieves up to the 100% accuracy. This is likely to be an optimistically biased
classification, chiefly due to the application of the same data for both model develop-
ment and model validation. A considerably more promising result was obtained in the
case of colon cancer dataset (94% accuracy) and CNS dataset (95% accuracy). There
is no denying that the multi-class classification provided the worst results, attaining
67% accuracy for SMO classifier.
As far as the results pertaining to the InfoGain-filtered Correlation-based Feature
Selection method are concerned, again too optimistic, biased classification accura-
cies were observed (100% classification accuracy). The most statistically meaningful
results were obtained in the case of CNS cancer dataset (98% accuracy using SMO
model), with the reduced number of features from 7070 to only 38 genes. In the case
of multi-class GCM dataset, the most promising results (81% of instances classified
correctly) were attained for the combination of SMO classifier and InfoGain-filtered
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Table 2. Best classification results without feature selection.
Dataset Classif. No. of Comparison criteria
method features
ALL/AML SMO 7070 ACC = 100.000 SENS = 1.000
SPEC = 1.000 FP rate = 0.000
RMSE = 0.000
CNS SMO 7070 ACC = 95.000 SENS = 0.950
SPEC = 0.929 FP rate = 0.071
RMSE = 0.224
Colon SMO 1988 ACC = 93.548 SENS = 0.935
SPEC = 0.924 FP rate = 0.076
RMSE = 0.254
Lung LMT 12533 ACC = 96.059 SENS = 0.961
SPEC = 0.945 FP rate = 0.055
RMSE = 0.121
Lymphoma SMO 4026 ACC = 94.792 SENS = 0.948
SPEC = 0.987 FP rate = 0.013
RMSE = 0.266
GCM SMO 16004 ACC = 67.361 SENS = 0.674
SPEC = 0.981 FP rate = 0.019
RMSE = 0.245
CFS method. Additionally, SMO classifier appeared to provide the best average clas-
sification accuracy when combined with CFS. In the case of various combinations of
classifiers and chi-squared filter attribute selection method, SMO appeared to provide
the best classification accuracies amongst all the other pairs of solutions. Besides in
general too optimistic, biased accuracies obtained for ALL/AML dataset, the best
results were observed in the case of lung cancer binary set of data (97% accuracy).
The classification accuracies obtained in the case of pairwise combinations of clas-
sification models and InfoGain feature selection method (applied individually, not as
a pre-processing step) appeared to be worse than in the case of a hybrid approach
(InfoGain/CFS feature selection). The results occurred to be statistically worse par-
ticularly in the case of GCM dataset consisting of multiple classes of cancer. Unfor-
tunately, nearly 60% classification accuracy cannot be regarded as a meaningful and
satisfactory outcome (in the case of InfoGain/CFS-SMO hybrid method as much as
81% was observed). The GainRatio feature selection method appeared to provide the
most satisfactory classification accuracies when combined with Sequential Minimal
Optimization (SMO) algorithm.
Symmetrical uncertainty-based filter method provided the best classification out-
comes when combined with SMO classifier. The GCM multi-class cancer dataset
attained up to 58% classification accuracy with respect to LMT classifier. The CNS
dataset was classified satisfactorily using SMO technique.
ReliefF feature selection method provided satisfactory results for the majority
of both binary and multi-class tumour sets of data. In the case of GCM dataset,
again the classification accuracy appeared to be worse than expected (up to 58%
cancer instances classified correctly using LMT classifier). The most reliable results
were obtained for the lung cancer dataset (99% classification accuracy using Na¨ıve
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Table 3. Best classification results for datasets with feature selection.
Dataset Classif. FS No. of Comparison criteria
method features
ALL/AML CFS SMO 34 ACC = 100.000 SENS = 1.000
SPEC = 1.000 FP rate = 0.000
RMSE = 0.000
ALL/AML Chi-squared SMO 150 ACC = 100.000 SENS = 1.000
SPEC = 1.000 FP rate = 0.000
RMSE = 0.000
CNS InfoGain SMO 150 ACC = 95.000 SENS = 0.950
SPEC = 0.929 FP rate = 0.071
RMSE = 0.224
CNS SymmUncer SMO 150 ACC = 95.000 SENS = 0.950
SPEC = 0.929 FP rate = 0.071
RMSE = 0.224
Colon SVM-RFE SMO 150 ACC = 95.161 SENS = 0.952
SPEC = 0.932 FP rate = 0.068
RMSE = 0.220
Lung Chi-squared SMO 150 ACC = 97.044 SENS = 0.970
SPEC = 0.946 FP rate = 0.054
RMSE = 0.318
Lung ReliefF Naive Bayes 150 ACC = 98.551 SENS = 0.986
SPEC = 0.967 FP rate = 0.033
RMSE = 0.076
Lymphoma CFS Naive Bayes 152 ACC = 100.000 SENS = 1.000
SPEC = 1.000 FP rate = 0.000
RMSE = 0.000
Lymphoma Chi-squared Naive Bayes 150 ACC = 93.939 SENS = 0.939
SPEC = 0.981 FP rate = 0.019
RMSE = 0.062
Lymphoma GainRatio LMT 150 ACC = 78.125 SENS = 0.781
SPEC = 0.950 FP rate = 0.050
RMSE = 0.183
GCM CFS SMO 42 ACC= 81.250 SENS = 0.813
SPEC = 0.989 FP rate = 0.011
RMSE = 0.243
GCM InfoGain SMO 150 ACC= 59.722 SENS = 0.597
SPEC = 0.976 FP rate = 0.024
RMSE = 0.246
GCM SVM-RFE SMO 150 ACC = 73.611 SENS = 0.736
SPEC = 0.984 FP rate = 0.016
RMSE = 0.244
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Table 4. Comparison of no. of features and accuracy with and without FS.
Dataset No. of No. of Features ACC ACC ACC
features features reduction without FS after FS diff
without FS after FS [%] [%]
ALL/AML 7070 34 99.52 100.00 100.00 0.00
CNS 7070 150 97.88 95.00 95.00 0.00
Colon 1988 150 92.45 93.55 95.16 +1.61
Lung 12533 150 98.80 96.06 98.55 +0.967
Lymphoma 4026 150 96.27 94.79 93.94 −0.85
GCM 16004 42 99.74 67.36 81.25 +13.89
Bayes classifier), while the most optimistic ones (100% classification accuracy) for
the lymphoma and ALL/AML datasets. ReliefF-SMO combination appeared to be
successful with respect to the colon cancer dataset (89% accuracy).
The combination of Information Gain/SVM-RFE/SMO hybrid classifier can be
regarded as the most accurate one, providing up to 74% accuracy on the most prob-
lematic multi-class GCM dataset. As far as the remaining sets of data are concerned,
over 90% classification accuracy was obtained in each of the considered cases. Be-
sides, taking into consideration the lymphoma dataset, Na¨ıve Bayes classifier provided
the most optimistic results (100% classification accuracy), suggesting that the appli-
cation of the same data for model development and model validation results in the
undesirable classification bias.
The comparison of numbers of features and accuracies for all datasets with and
without feature selection methods is presented in Table 4. It is noticeable that by
performing feature selection on high-dimensional tumour datasets we can significantly
reduce the attribute space with slight loss of accuracy. The best pairwise combinations
produced the reduction of features equalled more than 92% and the accuracy decrease
less than 1%. In the cases of colon, lung and GCM datasets the best classification
results were even better after feature selection applied than before for the whole
dataset, which may be observed in the cases, where the search for the best feature set
is still an active research topic [5].
4. Conclusions and future work
Classification of high-dimensional biomedical datasets is regarded as a challenging
task, requiring extremely high accuracy and as short computational time as possible.
There is no denying that the enormous dimensionality of the microarray expression
data is a serious concern during gene selection. All of the already reported results
concerning attribute selection methods in terms of microarray data suggest that multi-
class classification issues are typically more difficult than the binary ones. Therefore
research on finding the most appropriate methods for a multi-class classification are
conducted and often succeed in new approaches like in [10] by Podolak et al. Moreover
60
classification datasets often have an unequal class distribution among their examples.
This problem is known as imbalanced classification. To overcome the problems pro-
duced by noisy and borderline examples in imbalanced datasets, new methods are
introduced in Sa´ez et al. [12].
By comparing all the possible pairwise combinations of classification algorithms
and feature selection methods, it was demonstrated that the hybrid strategy resulted
in the most satisfactory outcomes and confirmed other up-to-date researches on mul-
tiple classifier systems led by Woz´niak et al. [16] and Kumar et al. [6]. In order to
specifically tailor the hybrid approach so that the high classification accuracy is to
be obtained regardless of the set of input data, one has to take into account a va-
riety of aspects. Moreover, the question remains whether it is possible to discover
the optimal number of genes to be selected by ranking methods. These, and all the
other circumstances, contribute to the difficulties related to finding the optimal and
universal feature selection and classification method, specifically tailored to handle
biomedical datasets.
It was successfully proved that the SMO classifier outperforms other classification
methods in the majority of cases, regardless of the input dataset used for the purpose
of training the model. As far as the attribute selection is concerned, the SVM-RFE
approach appeared to be perfectly suited for classification using SMO method. In
order to reduce the computational complexity of the classifier, each of the biomedical
datasets used in this paper were pre-processed by removing the housekeeping genes,
normalization and more importantly, by using the information gain-based filter, sig-
nificantly reducing the number of genes subjected to the classification task. Basically,
the genes filtered using information gain feature selector proved to be considerably
more informative for the SMO classifier. SVM-RFE algorithm was already demon-
strated to be the most reliable and efficient feature selection method when compared
to others, as well as the SVM-RFE algorithm combined with SMO classification was
considered as the most beneficial choice for constructing the learning model in the
studies of both Li et al. [7, 8].
Future studies ought to involve other algorithms and strategies as well, especially
those ones specifically tailored to deal with the most challenging multi-class cancer
classification tasks. In order to find the optimal solutions, other combinations of
various classifiers and attribute selectors should be investigated in depth.
5. References
[1] Chang C.-W., Cheng W.-C., Chen C.-R., Shu W.-Y., Tsai M.-L.,
et al., Identification of Human Housekeeping Genes and Tissue-Selective
Genes by Microarray Meta-Analysis. PLoS ONE, 2011, 6(7): e22859,
doi:10.1371/journal.pone.0022859.
[2] Dougherty E.R., Hua J., Sima C., Performance of Feature Selection Methods.
Curr. Genomics. 2009, 10, pp. 365–374.
61
[3] Eisenberg E., Levanon E.Y., Human housekeeping genes, revisited. Trends in
Genetics, October 2013, 29(10), pp. 569–574, doi:10.1016/j.tig.2013.05.010.
[4] Guyon I., Weston J., Barnhill S., Vapnik V., Gene selection for cancer classifi-
cation using support vector machines. Machine Learning, 2002, 46, pp. 389–422.
[5] Janecek A., Gansterer W., Demel W., Ecker G., On the relationship between
feature selection and classification accuracy. Journal of Machine Learning and
Research, 2008, 4, pp. 90–105.
[6] Kumar A.P., Valsala P., Feature Selection for high Dimensional DNA Microarray
data using hybrid approaches. Bioinformation, 2013, 9(16), pp. 824–828.
[7] Li X., Lu H., Wang M., A Hybrid Gene Selection Method for Multi-category
Tumor Classification using Microarray Data. Int. J. Bioautomation, 2013, 17(4),
pp. 249–258.
[8] Li X., Peng S., Zhan X., Zhang J., Xu Y., Comparison of feature selection meth-
ods for multiclass cancer classification based on microarray data. Proceedings
of the 4th International Conference on Biomedical Engineering and Informatics
(BMEI), 2011, 3, pp. 1692–1696.
[9] Liu G., Kong L., Gopalakrishnan V., A Partitioning Based Adaptive Method
for Robust Removal of Irrelevant Features from High-dimensional Biomedical
Datasets. AMIA Summits on Translational Science Proceedings, 2012, pp. 52–61.
[10] Podolak I. T., Roman A., CORES: fusion of supervised and unsupervised training
methods for a multi-class classification problem. Pattern Analysis and Applica-
tions, 2011, 14, pp. 395–413.
[11] Saeys Y., Inaki I., Larranaga P., A review of feature selection techniques in bioin-
formatics. Bioinformatics, 2007, 23(19), pp. 2507–2517.
[12] Sa´ez J.A., Luengo J., Stefanowski J., Herrera F., SMOTE-IPF: Addressing
the noisy and borderline examples problem in imbalanced classification by a re-
sampling method with filtering. Information Sciences, 10 January 2015, 291, pp.
184–203, http://dx.doi.org/10.1016/j.ins.2014.08.051.
[13] Trevino V., Falciani F., Barrera-Saldana H.A., DNA Microarrays: a Powerful
Genomic Tool for Biomedical and Clinical Research. Molecular Medicine, 2007,
13(9–10), pp. 527–541.
[14] Wang X., Gotoh O., A Robust Gene Selection Method for Microarray-based Can-
cer Classification. Cancer Informatics, 2010, 9, pp. 15–30.
[15] Wang Y., Tetko I.V., Hall M.A., Frank E., Facius A., Mayer K.F., Gene selec-
tion from microarray data for cancer classification–a machine learning approach.
Comput. Biol. Chem., 2005, 29, pp. 37–46.
[16] Woz´niak M., Graa M., Corchado E., A survey of multiple classifier systems as
hybrid systems. Information Fusion, 2014, 16, pp. 3–17.
62
[17] Zhang H., Wang H., Dai Z., Chen M.S., Yuan Z., Improving accuracy for can-
cer classification with a new algorithm for genes selection. BMC Bioinformatics,
2012, 13 (298), pp. 1.
